All three drugs target the epidermal growth factor receptor (EGFR), a protein that is over-expressed in cancer cells.
FORBES: Magazine Article
The public has mostly focused on Erbitux's ability to slow tumor growth by blocking epidermal growth factor receptor, a key growth-promoting protein that is overabundant in many cancer cells.
FORBES: Bristol, ImClone File On Erbitux
应用推荐
模块上移
模块下移
不移动